0001104659-20-083784.txt : 20200715 0001104659-20-083784.hdr.sgml : 20200715 20200715170040 ACCESSION NUMBER: 0001104659-20-083784 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200714 FILED AS OF DATE: 20200715 DATE AS OF CHANGE: 20200715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malin Life Sciences Holdings Ltd CENTRAL INDEX KEY: 0001685138 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39376 FILM NUMBER: 201030023 BUSINESS ADDRESS: STREET 1: 2 HARBOUR SQUARE STREET 2: CROFTON ROAD CITY: DUN LAOGHAIRE, CO, DUBLIN STATE: L2 ZIP: ---- BUSINESS PHONE: 353 1 901 5701 MAIL ADDRESS: STREET 1: 2 HARBOUR SQUARE STREET 2: CROFTON ROAD CITY: DUN LAOGHAIRE, CO, DUBLIN STATE: L2 ZIP: ---- REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malin Corp plc CENTRAL INDEX KEY: 0001673063 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39376 FILM NUMBER: 201030024 BUSINESS ADDRESS: STREET 1: 2 HARBOUR SQUARE STREET 2: CROFTON ROAD CITY: DUN LAOGHAIRE, CO. DUBLIN STATE: L2 ZIP: ----- BUSINESS PHONE: 353 1 901 5701 MAIL ADDRESS: STREET 1: 2 HARBOUR SQUARE STREET 2: CROFTON ROAD CITY: DUN LAOGHAIRE, CO. DUBLIN STATE: L2 ZIP: ----- ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Poseida Therapeutics, Inc. CENTRAL INDEX KEY: 0001661460 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 472846548 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9390 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-779-3100 MAIL ADDRESS: STREET 1: 9390 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 a4.xml 4 X0306 4 2020-07-14 0 0001661460 Poseida Therapeutics, Inc. PSTX 0001685138 Malin Life Sciences Holdings Ltd THE LENNOX BUILDING 50 RICHMOND STREET SOUTH DUBLIN L2 D02 FK02 IRELAND 0 0 1 0 0001673063 Malin Corp plc THE LENNOX BUILDING 50 RICHMOND STREET SOUTH DUBLIN L2 D02 FK02 IRELAND 0 0 1 0 Common Stock 2020-07-14 4 C 0 7013918 A 7013918 D Common Stock 2020-07-14 4 C 0 1168985 A 8182903 D Common Stock 2020-07-14 4 C 0 690124 A 8873027 D Common Stock 2020-07-14 4 C 0 315098 A 9188125 D Series A Preferred Stock 2020-07-14 4 C 0 8746356 D Common Stock 7013918 0 D Series A-1 Preferred Stock 2020-07-14 4 C 0 1457725 D Common Stock 1168985 0 D Series B Preferred Stock 2020-07-14 4 C 0 860585 D Common Stock 690124 0 D Series C Preferred Stock 2020-07-14 4 C 0 392927 D Common Stock 315098 0 D All shares of preferred stock, $0.0001 par value per share, of the Issuer, (i) had no expiration date and (ii) automatically converted into the Issuer's common stock, $0.0001 par value per share, on a 1-for-0.8019246 basis immediately prior to the closing of the Issuer's initial public offering. Malin Life Sciences Holdings Ltd, the record holder of the shares, is a wholly owned subsidiary of Malin Corporation plc. Malin Corporation plc may be deemed to beneficially own the shares and may be deemed to share voting and dispositive power over these shares. (1) Exhibit 24 - Power of Attorney (incorporated by reference to Power of Attorney filed as Exhibit 24 to the Form 3 filed by the Reporting Persons on July 9, 2020) (2) Exhibit 99.1 - Joint Filer Information Malin Life Sciences Holdings Ltd, By: /s/ Michael A. Goldstein, Esq., Attorney-in-Fact 2020-07-15 Malin Corporation plc, By: /s/ Michael A. Goldstein, Esq., Attorney-in-Fact 2020-07-15 EX-99.1 2 ex-99d1.htm EX-99.1

Exhibit 99.1

 

FORM 4 JOINT FILER INFORMATION

 

Names of Joint Filers:

Malin Life Sciences Holdings Ltd

Malin Corporation plc

 

Address of Joint Filers:

The Lennox Building

50 Richmond Street South

Dublin

D02 FK02

Ireland

 

Designated Filer:

Malin Life Sciences Holdings Ltd

 

Issuer and Ticker Symbol:

Poseida Therapeutics, Inc. [PSTX]

 

Date of Event:

July 14, 2020

 

Signatures of Joint Filers:

 

Malin Life Sciences Holdings Ltd

 

By:

/s/ Michael A. Goldstein, Esq.

 

 

Attorney-in-Fact

 

 

 

 

Malin Corporation plc

 

 

 

 

By:

/s/ Michael A. Goldstein, Esq.

 

 

Attorney-in-Fact